These results, together with a past report displaying that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 support the principle of targeting ACKR3 as a novel strategy to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated Issues. In reaction to this issue, https://kingdome925eaw2.bloggadores.com/profile